Entera Bio Ltd. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Kesselman & Kesselman, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.44 USD | -6.15% | -0.81% | +306.67% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+306.67% | 87.32M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- ENTX Stock
- News Entera Bio Ltd.
- Entera Bio Ltd. Auditor Raises 'Going Concern' Doubt